There is abundant evidence that tumor-infiltrating CD8+ T cells contribute positively to antitumor immunity; however, the role of tumor-infiltrating B cells (TIL-B) and plasma cells …
S Wang, W Liu, D Ly, H Xu, L Qu, L Zhang - Cellular & molecular …, 2019 - nature.com
Evidence indicates that lung cancer development is a complex process that involves interactions between tumor cells, stromal fibroblasts, and immune cells. Tumor-infiltrating …
The clinical relevance of the host immune system in breast cancer has long been unexplored. Studies developed over the past decade have highlighted the biological …
R Salgado, C Denkert, S Demaria, N Sirtaine… - Annals of oncology, 2015 - Elsevier
Evidence is strengthening for the morphological evaluation of tumor infiltrating lymphocytes (TILs) in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists …
C Denkert, G Von Minckwitz, JC Brase… - Journal of clinical …, 2015 - ascopubs.org
Purpose Modulation of immunologic interactions in cancer tissue is a promising therapeutic strategy. To investigate the immunogenicity of human epidermal growth factor receptor 2 …
S Olbrecht, P Busschaert, J Qian, A Vanderstichele… - Genome Medicine, 2021 - Springer
Background High-grade serous tubo-ovarian cancer (HGSTOC) is characterised by extensive inter-and intratumour heterogeneity, resulting in persistent therapeutic resistance …
Abstract Purpose: CD8+ tumor-infiltrating lymphocytes (TIL) are key mediators of antitumor immunity and are strongly associated with survival in virtually all solid tumors. However, the …
Conventional chemotherapeutics and targeted antineoplastic agents have been developed based on the simplistic notion that cancer constitutes a cell-autonomous genetic or …
Multiple independent studies have shown that tumor-infiltrating lymphocytes (TIL) are prognostic in breast cancer with potential relevance for response to immune-checkpoint …